Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT00070447 · COMPLETED
Trial details
- NCT number
- NCT00070447
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.